首页|期刊导航|中华医学杂志（英文版）|Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty:a randomized controlled trial

Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty:a randomized controlled trial

Yi Ren Shi-Liang Cao Zeng Li Tim Luo Bin Feng Xi-Sheng Weng

中华医学杂志（英文版）2021，Vol.134Issue(2)：164-172,9.

中华医学杂志（英文版）2021，Vol.134Issue(2)：164-172,9.DOI:10.1097/CM9.0000000000001305

Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty:a randomized controlled trial

Yi Ren ¹Shi-Liang Cao ²Zeng Li ¹Tim Luo ³Bin Feng ¹Xi-Sheng Weng¹

作者信息

1. Department of Orthopedic Surgery,Peking Union Medical College Hospital,Peking Union Medical College,Beijing 100730,China
2. Department of Orthopaedic Surgery,Peking University Third Hospital,Peking University,Beijing 100191,China
3. Doctor of Medicine Program,University of Alberta,Edmonton,AB T6G 2R3,Canada
折叠

摘要

关键词

Total hip arthroplasty/Aspirin/Rivaroxaban/Venous thromboembolism/Blood loss/Complication

Key words

Total hip arthroplasty/Aspirin/Rivaroxaban/Venous thromboembolism/Blood loss/Complication

引用本文复制引用

Yi Ren,Shi-Liang Cao,Zeng Li,Tim Luo,Bin Feng,Xi-Sheng Weng..Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty:a randomized controlled trial[J].中华医学杂志（英文版）,2021,134(2):164-172,9.

基金项目

This work was supported by the National Nature Science Foundation in China(No.81871740). （No.81871740）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINESCI

ISSN：0366-6999

访问量0

下载量0

段落导航